US to sue his parents for dealing him an inferior hand of genes.
Fetuses are today commonly screened for genetic disorders and this service will no doubt expand. An American company has devised a one-inch chip carrying 400,000 DNA fragments, which will allow the entire human genome to be screened for an average of four alleles per gene. The difference between eliminating the undesirable and promoting the advantageous is becoming too subtle even for ethical hair-splitting. Those who reject the lot as contrary to God's will are the descendants of the sanctimonious bigots who sought to prevent the application of effective treatments for leprosy and syphilis, when these became available earlier this century. Nor can one argue that the new genetic techniques signal a return to the malign eugenics of earlier days, for they will be driven not by the state or any other authority but by the aspirations of individual citizens.
Silver makes a genuflection in his subtitle and epigraph to Aldous Huxley, while rejecting any comparisons with the dystopia of Brave New World. But as the technology will always be exacting and expensive, genetic enhancement will remain the prerogative of the rich. So in time two populations will emerge, which Silver calls the GenRich and the Naturals, who will seldom intermarry. The genetic distance between the two groups will widen until they are no longer able to interbreed and evolution will have been given a sharp nudge.
This (like the entire book) is vastly entertaining stuff, but biologists will perceive the weakness in Silver's jeu d'esprit: almost all diseases, and certainly all mental and physical attributes, are clearly enough multigenic and interact in complex and uncertain ways with the environment. Silver believes that science will in time get to grips with all such problems; his prediction will send shivers up many spines but not, I suspect, those of geneticists.
Silver unexpectedly stops short of the last frontier -the conquest of mortality. Whether this emerges from the study of telomeres or the mutation in progeria or from some other, unforeseen direction, it is surely likely to overwhelm the human species long before the designer babies start to pop out of the womb. Meanwhile, to banish the unpleasing vision of a genetic aristocracy poring over the DNA stud-book, just as the inbred nineteenth-century nobility of Europe immersed itself endlessly in the Almanach de Gotha, remember the report once given by a cavalry officer on one of his high-born subordinates: "Personally, I would not breed from this officer." Listeria are Gram-positive bacteria that are commonly found in foodstuffs, particularly unpasteurised dairy products. For most people Listeria are not hazardous, but infection is a serious health problem for pregnant women, the immunodepressed and the elderly. After ingestion in food, the bacteria are taken up by the host's macrophages and distributed as the infected cells circulate in the bloodstream throughout the body. Once inside a macrophage, the bacteria secrete enzymes to release themselves from the cell's ingestion organelle, the phagosome; the bacteria then multiply, and move within the macrophage until they reach the plasma membrane and are engulfed by other adjacent cells. By 'hiding' inside macrophages and other cells, Listeria effectively avoid the circulating antibodies of the host while continuing to propagate.
Although they observed static images, Tilney and Portnoy deduced that the actin comet tails might be responsible for moving the bacteria through the cell, and that studies of Listeria might be useful to test ideas about the everyday dynamics of the actin cytoskeleton. Sight of these comets led a number of laboratories working on the actin cytoskeleton to change direction and pursue the problem of F-actin-directed movement of Listeria.
The ability to form actin comets comes from a Listeria protein, ActA, which is expressed on the bacterial surface. There are many unresolved steps between the expression of ActA protein and making an actin-filled, force-generating comet, but it seems clear that the bacteria use many of the proteins that are present in normal cellular actin-based structures.
I missed the Tilney and Portnoy paper in 1989, but I had had the pleasure of attending seminars by Tilney during several summers at the Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts. Among the many excellent seminars on molecular, cellular and developmental biology during the Embryology course, Tilney's -on propulsive actin polymerization in the sperm of the sea cucumber Thyone -were the most memorable. He combined seemingly simple electron microscopic observation with critical thinking to clarify complex problems.
My introduction to Tilney's Listeria papers came when I sought a post-doctoral position with Daniel Louvard at the Institut Pasteur in Paris. I had previously studied mitosis and wanted to learn about the behaviour of the actin cytoskeleton during mitosis, in particular at cytokinesis. I was directed to Louvard's associate, Evelyne Friederich, who had recently set up a project based upon studies of Listeria. She and others transfected human cultured cells with actA cDNAs with dramatic effects: the cells filled up with actin filaments and sent off numerous membrane-bound cytoplasmic extensions [2] . This result suggested that human cells have proteins that react specifically with ActA, so they might also have a natural ligand -a human ActA-like protein. The research project on offer was to identify ActA-like proteins of human cells using ActA-specific antibodies -a long way from my aim of studying cytokinesis.
But the project was enticing for several reasons. The laboratory had considerable experience in moving from cross-reacting antibodies to models of how a protein might function, and the evolutionary origins of the actA gene were in question because only two of the six Listeria species carry actA -the same two species that can form cometssuggesting that the gene might at one time have been acquired from another genome, possible mammalian. But it was a literature search on the subject that helped close the deal. Many of the papers on ActA cited Tilney in their introduction, including the seminal 1989 paper [1] . Upon reading this paper and remembering Tilney's seminars at MBL, I dropped the idea of studying cytokinesis to join Friederich's group and study ActA instead.
In the 1989 paper, Tilney and Portnoy wrote that their findings "should be exciting to cell biologists who want to know how actin filaments become organised in cells" [1] . Many authors throw in such a phrase about their results, but this time it was true. Studies of ActA have already uncovered a number of important cytoskeletal proteins: with Mary Beckerle, we found zyxin, while Trinad Chakraborty, Ulrich Walter and Jürgen Wehland and colleagues found that VASP (vasodilator stimulated phosphoprotein) binds to zyxin and to ActA, and the somewhat mysterious Arp2/3 complex of proteins resurfaced in Tim Mitchison's laboratory as being required for ActA-dependent actin polymerization -and all this was in just the first wave of molecular analysis of ActA.
Tilney has published other results on unusual properties of actin polymerization in a variety of species. I think it's safe to predict that there might still be a few turning points ahead for cell biologists who read his papers, even if they don't see comets. A Listeria bacterium (white) and its actin-filled comet (red) streak across the expanse of a cytoplasmic extract prepared from HeLa cells. Photograph courtesy of E. Friederich, Institut Curie, Paris.
